Intervention of cognitive reassessment on rumination thinking in breast cancer patients during postoperative chemotherapy

ISRCTN ISRCTN64054642
DOI https://doi.org/10.1186/ISRCTN64054642
Submission date
31/08/2024
Registration date
03/09/2024
Last edited
02/09/2024
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
This study aims to create a cognitive reappraisal intervention program on ruminative thought in breast cancer patients undergoing postoperative chemotherapy and to evaluate its clinical application effect in order to provide a reference for the emotional symptom management of breast cancer patients.

Who can participate?
Breast cancer patients aged 18 years and over undergoing postoperative chemotherapy

What does the study involve?
From June 2022 to November 2022, breast cancer patients in the postoperative chemotherapy period who met the acceptance criteria were continuously included in the breast surgery department of two Class A tertiary hospitals in Suzhou. The patients were divided into a control group and a cognitive reappraisal group using a random number table. During the hospitalization of the control group, nursing staff provided nursing, health education, and rehabilitation guidance in accordance with the routine nursing care of breast surgery specialists. At the four intervention timepoints, they entered the pre-arranged activity room and received one-on-one routine psychological care from the department. After discharge, the patient underwent routine telephone follow-up; The intervention duration was four chemotherapy cycles. On the basis of the control group, patients in the cognitive reappraisal group entered the activity room at the same intervention time point to receive a one-on-one cognitive reappraisal intervention program on ruminative thought, including four thematic interventions: mutual familiarity, cognitive reappraisal symptom rumination intervention, cognitive reappraisal compulsive meditation intervention, and cognitive reappraisal reflection contemplation intervention. Ruminative thought levels and depressive emotions of the two groups of patients were measured before the first intervention and after the second, third, and fourth interventions.

What are the possible benefits and risks of participating?
Possible benefits include reduced ruminative thoughts and depression. There are no expected risks.

Where is the study run from?
The First Affiliated Hospital of Soochow University and the Second Affiliated Hospital of Soochow University (China)

When is the study starting and how long is it expected to run for?
December 2021 to May 2024

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Yueyue Zhang, 15850130176@163.com

Contact information

Miss Yueyue Zhang
Public, Scientific, Principal Investigator

No.1 Shizi Street
Gusu District
Suzhou City
Jiangsu Province
Su zhou
215000
China

Phone +86 (0)15850130176
Email 15850130176@163.com

Study information

Study designParallel randomized controlled study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeEfficacy
Participant information sheet Not available in web format, please use the contact details to request a participant information sheet
Scientific titleEffect of cognitive reappraisal on ruminative thought in breast cancer patients with postoperative chemotherapy
Study acronymCRRT
Study objectivesIn this study, the cognitive reappraisal intervention scheme of ruminative thought in breast cancer patients during postoperative chemotherapy can reduce ruminative thought level and alleviate depression.
Ethics approval(s)

Approved 04/03/2022, Ethics Committee of Soochow University (No.1 Shizi Street, Gusu District, Suzhou City, 215000, China; +86 (0)65884048; guangyinxu@suda.edu.cn), ref: SUDA20220304H04

Health condition(s) or problem(s) studiedBreast cancer
InterventionParticipants were randomly divided into a control group and a cognitive reappraisal group according to a random number table. In order to avoid contamination between the two groups, both the control group and the cognitive reappraisal group were asked to enter a pre-arranged activity room for one-on-one communication with the researchers and were told to keep the communication confidential because the study was still ongoing.

During the hospitalization of the control group, nursing staff provided nursing, health education, and rehabilitation guidance according to the routine nursing care of the breast surgery specialty. They entered the pre-arranged activity room at four intervention time points and received one-on-one routine psychological care from the department; After discharge, patients will receive routine telephone follow-up; The intervention duration is four chemotherapy cycles. On the basis of the control group, patients in the cognitive reappraisal group entered the activity room at the same intervention time to receive one-on-one rumination thinking cognitive reappraisal intervention, including four thematic interventions: mutual familiarity, cognitive reappraisal symptom rumination intervention, cognitive reappraisal compulsive meditation intervention, and cognitive reappraisal reflection deep thinking intervention.
Intervention typeSupplement
Primary outcome measureRuminative thought is measured using a Ruminative Responses Scale (RRS) at baseline, 4, 7, and 10 weeks
Secondary outcome measuresDepression is measured using a Self-Rating Depression Scale (SDS) at baseline, 4, 7, and 10 weeks
Overall study start date01/12/2021
Completion date24/05/2024

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexFemale
Target number of participants64
Total final enrolment68
Key inclusion criteria1. Female patients diagnosed with breast cancer by pathological report
2. Age 18 years and above
3. Tumor Node Metastasis (TNM) stages I-III
4. First four cycles of postoperative adjuvant chemotherapy
5. Understanding one's own disease diagnosis without the need for protective medical care
6. Having certain abilities in reading, writing, comprehension, and language expression
7. Informed consent and voluntary participation in this study
Key exclusion criteria1. Individuals with severe physical diseases such as other malignant tumors
2. Individuals with organic brain diseases or combined with other mental disorders
3. Patients who have recently participated in other psychological interventions or received psychotherapy
Date of first enrolment01/06/2022
Date of final enrolment30/11/2022

Locations

Countries of recruitment

  • China

Study participating centres

First Affiliated Hospital of Soochow University
215000
China
Second Affiliated Hospital of Soochow University
215000
China

Sponsor information

Soochow University
University/education

No.1 Shizi Street
Gusu District
Suzhou City
Jiangsu Province
Suzhou
215000
China

Phone +86 (0)13862596317
Email tianlisz@suda.edu.cn
Website http://eng.suda.edu.cn/
ROR logo "ROR" https://ror.org/05t8y2r12

Funders

Funder type

Other

Investigator initiated and funded

No information available

Results and Publications

Intention to publish date31/12/2024
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request, Published as a supplement to the results publication
Publication and dissemination planThe paper has been submitted to a journal
IPD sharing planThe datasets generated and/or analysed during the current study will be published as a supplement to the results publication.

Editorial Notes

02/09/2024: Study's existence confirmed by the Ethics Committee of Soochow University.